| 1 | participated | 7,045 |
| 2 | residing | 469 |
| 3 | resided | 99 |
| 4 | specializing | 67 |
| 5 | specialising | 17 |
| 6 | indulged | 7 |
| 7 | specializes | 6 |
| 8 | matriculated | 5 |
| 9 | -3-methyl-1,3-pentadiene | 4 |
| 10 | -thrombolysis | 4 |
| 11 | cells/square | 4 |
| 12 | reengaged | 4 |
| 13 | atom/l | 3 |
| 14 | h·mg/l | 3 |
| 15 | majored | 3 |
| 16 | phenyl-p | 3 |
| 17 | -assay | 2 |
| 18 | .colloids | 2 |
| 19 | 2-thrombolysis | 2 |
| 20 | c-verapamil | 2 |
| 21 | didnt | 2 |
| 22 | min/tooth | 2 |
| 23 | nebula | 2 |
| 24 | nh-responsive | 2 |
| 25 | partook | 2 |
| 26 | pyridine-2-amines | 2 |
| 27 | standl | 2 |
| 28 | wisdoms | 2 |
| 29 | ±oglds | 2 |
| 30 | 'decrease | 1 |
| 31 | +hcn | 1 |
| 32 | +tio | 1 |
| 33 | -1,3-dioxolanes | 1 |
| 34 | -1-vinylpyrroles | 1 |
| 35 | -1h-pyrazoles | 1 |
| 36 | -2/9 | 1 |
| 37 | -3-brpa | 1 |
| 38 | -3-hexen-1-ol | 1 |
| 39 | -5-and-6-carboxy-fluorescein | 1 |
| 40 | -acrylate | 1 |
| 41 | -alpha-yohimbine | 1 |
| 42 | -benzoyl-5'-o-levulinoyl-2'-deoxyadenosine-3'-o-tetraphosphate | 1 |
| 43 | -boosters | 1 |
| 44 | -challenge | 1 |
| 45 | -concentration | 1 |
| 46 | -dienylsilanes | 1 |
| 47 | -en-8-ones | 1 |
| 48 | -enantioselectivity | 1 |
| 49 | -extubation | 1 |
| 50 | -gamma1b | 1 |
| 51 | -generators | 1 |
| 52 | -homoisoleucine | 1 |
| 53 | -isobutyrylguanosine | 1 |
| 54 | -methanesulfonohydrazides | 1 |
| 55 | -mybpc3 | 1 |
| 56 | -norepinephrine | 1 |
| 57 | -o-phenylenediamines | 1 |
| 58 | -orbital | 1 |
| 59 | -petromyroxol | 1 |
| 60 | -piperidine-2-carboxylate | 1 |
| 61 | -pyrimidinedione | 1 |
| 62 | -relaxometry | 1 |
| 63 | -resulted | 1 |
| 64 | -secretion | 1 |
| 65 | -specialists | 1 |
| 66 | -subfractions | 1 |
| 67 | -uva | 1 |
| 68 | -β-aminomalonates | 1 |
| 69 | .bsi | 1 |
| 70 | .tolerability | 1 |
| 71 | /b-victoria/b-yamagata | 1 |
| 72 | /carbo | 1 |
| 73 | /docetaxel | 1 |
| 74 | /s-las | 1 |
| 75 | /species | 1 |
| 76 | /sucrose | 1 |
| 77 | /trandolapril | 1 |
| 78 | /val | 1 |
| 79 | 06_cpx | 1 |
| 80 | 1.12-0.85 | 1 |
| 81 | 11.824 | 1 |
| 82 | 2-3.1 | 1 |
| 83 | 2-aryl-benzimidazoles | 1 |
| 84 | 2004–004693–87 | 1 |
| 85 | 2nme | 1 |
| 86 | 4.94±1.30 | 1 |
| 87 | 70-plus | 1 |
| 88 | 8.527 | 1 |
| 89 | 81,723 | 1 |
| 90 | =0.361 | 1 |
| 91 | =0.6607 | 1 |
| 92 | =0.7814 | 1 |
| 93 | =0.8599 | 1 |
| 94 | =0.9964 | 1 |
| 95 | a-g-c | 1 |
| 96 | aa-isoform | 1 |
| 97 | acquiesce | 1 |
| 98 | acrossjapan | 1 |
| 99 | alikeness | 1 |
| 100 | antoine-lacassagne | 1 |
| 101 | aucl/agntf2 | 1 |
| 102 | aucl/nabarf | 1 |
| 103 | bacteria/well | 1 |
| 104 | bród | 1 |
| 105 | buli | 1 |
| 106 | c-accumulation | 1 |
| 107 | c-flumazenil | 1 |
| 108 | ce-fcr | 1 |
| 109 | control-storage | 1 |
| 110 | cyclocoagulation | 1 |
| 111 | d'immunotherapie | 1 |
| 112 | dcfda-assay | 1 |
| 113 | diderot | 1 |
| 114 | died-20 | 1 |
| 115 | dithioesters | 1 |
| 116 | e1.1010 | 1 |
| 117 | eoc+p | 1 |
| 118 | fossilized | 1 |
| 119 | fulminans | 1 |
| 120 | function/expression | 1 |
| 121 | gu/cm2 | 1 |
| 122 | h-tg-fcr | 1 |
| 123 | hiv1-testing | 1 |
| 124 | hospitalysed | 1 |
| 125 | istosoma | 1 |
| 126 | klalit | 1 |
| 127 | majoring | 1 |
| 128 | microg/i | 1 |
| 129 | microspectrofluorimetry | 1 |
| 130 | minitabs/syrup | 1 |
| 131 | mm2kpa-1 | 1 |
| 132 | neuver | 1 |
| 133 | non-yet | 1 |
| 134 | on-device | 1 |
| 135 | oxime-bsa | 1 |
| 136 | part-educated | 1 |
| 137 | pdna-loaded | 1 |
| 138 | post-phototherapy | 1 |
| 139 | postpartumly | 1 |
| 140 | procrea | 1 |
| 141 | pyrazol-3-ones | 1 |
| 142 | re-enlarged | 1 |
| 143 | reaven | 1 |
| 144 | recertifying | 1 |
| 145 | reucrred | 1 |
| 146 | rs117078492 | 1 |
| 147 | rs7820268 | 1 |
| 148 | senesce | 1 |
| 149 | sesamine | 1 |
| 150 | showedhighfrequency | 1 |
| 151 | shunrin | 1 |
| 152 | sneezed | 1 |
| 153 | trial-conducted | 1 |
| 154 | twice/month | 1 |
| 155 | worsen-ninc | 1 |
| 156 | zr-dfo | 1 |
| 157 | zubirán | 1 |
| 158 | ×tt | 1 |
| 1 | 'decrease | 1 |
| 2 | +hcn | 1 |
| 3 | +tio | 1 |
| 4 | -1,3-dioxolanes | 1 |
| 5 | -1-vinylpyrroles | 1 |
| 6 | -1h-pyrazoles | 1 |
| 7 | -2/9 | 1 |
| 8 | -3-brpa | 1 |
| 9 | -3-hexen-1-ol | 1 |
| 10 | -3-methyl-1,3-pentadiene | 4 |
| 11 | -5-and-6-carboxy-fluorescein | 1 |
| 12 | -acrylate | 1 |
| 13 | -alpha-yohimbine | 1 |
| 14 | -assay | 2 |
| 15 | -benzoyl-5'-o-levulinoyl-2'-deoxyadenosine-3'-o-tetraphosphate | 1 |
| 16 | -boosters | 1 |
| 17 | -challenge | 1 |
| 18 | -concentration | 1 |
| 19 | -dienylsilanes | 1 |
| 20 | -en-8-ones | 1 |
| 21 | -enantioselectivity | 1 |
| 22 | -extubation | 1 |
| 23 | -gamma1b | 1 |
| 24 | -generators | 1 |
| 25 | -homoisoleucine | 1 |
| 26 | -isobutyrylguanosine | 1 |
| 27 | -methanesulfonohydrazides | 1 |
| 28 | -mybpc3 | 1 |
| 29 | -norepinephrine | 1 |
| 30 | -o-phenylenediamines | 1 |
| 31 | -orbital | 1 |
| 32 | -petromyroxol | 1 |
| 33 | -piperidine-2-carboxylate | 1 |
| 34 | -pyrimidinedione | 1 |
| 35 | -relaxometry | 1 |
| 36 | -resulted | 1 |
| 37 | -secretion | 1 |
| 38 | -specialists | 1 |
| 39 | -subfractions | 1 |
| 40 | -thrombolysis | 4 |
| 41 | -uva | 1 |
| 42 | -β-aminomalonates | 1 |
| 43 | .bsi | 1 |
| 44 | .colloids | 2 |
| 45 | .tolerability | 1 |
| 46 | /b-victoria/b-yamagata | 1 |
| 47 | /carbo | 1 |
| 48 | /docetaxel | 1 |
| 49 | /s-las | 1 |
| 50 | /species | 1 |
| 51 | /sucrose | 1 |
| 52 | /trandolapril | 1 |
| 53 | /val | 1 |
| 54 | 06_cpx | 1 |
| 55 | 1.12-0.85 | 1 |
| 56 | 11.824 | 1 |
| 57 | 2-3.1 | 1 |
| 58 | 2-aryl-benzimidazoles | 1 |
| 59 | 2-thrombolysis | 2 |
| 60 | 2004–004693–87 | 1 |
| 61 | 2nme | 1 |
| 62 | 4.94±1.30 | 1 |
| 63 | 70-plus | 1 |
| 64 | 8.527 | 1 |
| 65 | 81,723 | 1 |
| 66 | =0.361 | 1 |
| 67 | =0.6607 | 1 |
| 68 | =0.7814 | 1 |
| 69 | =0.8599 | 1 |
| 70 | =0.9964 | 1 |
| 71 | a-g-c | 1 |
| 72 | aa-isoform | 1 |
| 73 | acquiesce | 1 |
| 74 | acrossjapan | 1 |
| 75 | alikeness | 1 |
| 76 | antoine-lacassagne | 1 |
| 77 | atom/l | 3 |
| 78 | aucl/agntf2 | 1 |
| 79 | aucl/nabarf | 1 |
| 80 | bacteria/well | 1 |
| 81 | bród | 1 |
| 82 | buli | 1 |
| 83 | c-accumulation | 1 |
| 84 | c-flumazenil | 1 |
| 85 | c-verapamil | 2 |
| 86 | ce-fcr | 1 |
| 87 | cells/square | 4 |
| 88 | control-storage | 1 |
| 89 | cyclocoagulation | 1 |
| 90 | d'immunotherapie | 1 |
| 91 | dcfda-assay | 1 |
| 92 | diderot | 1 |
| 93 | didnt | 2 |
| 94 | died-20 | 1 |
| 95 | dithioesters | 1 |
| 96 | e1.1010 | 1 |
| 97 | eoc+p | 1 |
| 98 | fossilized | 1 |
| 99 | fulminans | 1 |
| 100 | function/expression | 1 |
| 101 | gu/cm2 | 1 |
| 102 | h-tg-fcr | 1 |
| 103 | hiv1-testing | 1 |
| 104 | hospitalysed | 1 |
| 105 | h·mg/l | 3 |
| 106 | indulged | 7 |
| 107 | istosoma | 1 |
| 108 | klalit | 1 |
| 109 | majored | 3 |
| 110 | majoring | 1 |
| 111 | matriculated | 5 |
| 112 | microg/i | 1 |
| 113 | microspectrofluorimetry | 1 |
| 114 | min/tooth | 2 |
| 115 | minitabs/syrup | 1 |
| 116 | mm2kpa-1 | 1 |
| 117 | nebula | 2 |
| 118 | neuver | 1 |
| 119 | nh-responsive | 2 |
| 120 | non-yet | 1 |
| 121 | on-device | 1 |
| 122 | oxime-bsa | 1 |
| 123 | part-educated | 1 |
| 124 | participated | 7,045 |
| 125 | partook | 2 |
| 126 | pdna-loaded | 1 |
| 127 | phenyl-p | 3 |
| 128 | post-phototherapy | 1 |
| 129 | postpartumly | 1 |
| 130 | procrea | 1 |
| 131 | pyrazol-3-ones | 1 |
| 132 | pyridine-2-amines | 2 |
| 133 | re-enlarged | 1 |
| 134 | reaven | 1 |
| 135 | recertifying | 1 |
| 136 | reengaged | 4 |
| 137 | resided | 99 |
| 138 | residing | 469 |
| 139 | reucrred | 1 |
| 140 | rs117078492 | 1 |
| 141 | rs7820268 | 1 |
| 142 | senesce | 1 |
| 143 | sesamine | 1 |
| 144 | showedhighfrequency | 1 |
| 145 | shunrin | 1 |
| 146 | sneezed | 1 |
| 147 | specialising | 17 |
| 148 | specializes | 6 |
| 149 | specializing | 67 |
| 150 | standl | 2 |
| 151 | trial-conducted | 1 |
| 152 | twice/month | 1 |
| 153 | wisdoms | 2 |
| 154 | worsen-ninc | 1 |
| 155 | zr-dfo | 1 |
| 156 | zubirán | 1 |
| 157 | ±oglds | 2 |
| 158 | ×tt | 1 |
| 1 | e1.1010 | 1 |
| 2 | died-20 | 1 |
| 3 | 4.94±1.30 | 1 |
| 4 | mm2kpa-1 | 1 |
| 5 | 2-3.1 | 1 |
| 6 | =0.361 | 1 |
| 7 | rs117078492 | 1 |
| 8 | aucl/agntf2 | 1 |
| 9 | gu/cm2 | 1 |
| 10 | 81,723 | 1 |
| 11 | -mybpc3 | 1 |
| 12 | =0.7814 | 1 |
| 13 | 11.824 | 1 |
| 14 | =0.9964 | 1 |
| 15 | 1.12-0.85 | 1 |
| 16 | =0.6607 | 1 |
| 17 | 8.527 | 1 |
| 18 | 2004–004693–87 | 1 |
| 19 | rs7820268 | 1 |
| 20 | -2/9 | 1 |
| 21 | =0.8599 | 1 |
| 22 | procrea | 1 |
| 23 | nebula | 2 |
| 24 | istosoma | 1 |
| 25 | -3-brpa | 1 |
| 26 | oxime-bsa | 1 |
| 27 | /b-victoria/b-yamagata | 1 |
| 28 | -uva | 1 |
| 29 | -gamma1b | 1 |
| 30 | a-g-c | 1 |
| 31 | worsen-ninc | 1 |
| 32 | pdna-loaded | 1 |
| 33 | resided | 99 |
| 34 | reengaged | 4 |
| 35 | indulged | 7 |
| 36 | re-enlarged | 1 |
| 37 | majored | 3 |
| 38 | reucrred | 1 |
| 39 | hospitalysed | 1 |
| 40 | part-educated | 1 |
| 41 | matriculated | 5 |
| 42 | participated | 7,045 |
| 43 | trial-conducted | 1 |
| 44 | -resulted | 1 |
| 45 | sneezed | 1 |
| 46 | fossilized | 1 |
| 47 | bród | 1 |
| 48 | on-device | 1 |
| 49 | acquiesce | 1 |
| 50 | senesce | 1 |
| 51 | control-storage | 1 |
| 52 | -challenge | 1 |
| 53 | d'immunotherapie | 1 |
| 54 | 2nme | 1 |
| 55 | -3-methyl-1,3-pentadiene | 4 |
| 56 | antoine-lacassagne | 1 |
| 57 | -alpha-yohimbine | 1 |
| 58 | -homoisoleucine | 1 |
| 59 | sesamine | 1 |
| 60 | -norepinephrine | 1 |
| 61 | -isobutyrylguanosine | 1 |
| 62 | -pyrimidinedione | 1 |
| 63 | cells/square | 4 |
| 64 | 'decrease | 1 |
| 65 | /sucrose | 1 |
| 66 | -benzoyl-5'-o-levulinoyl-2'-deoxyadenosine-3'-o-tetraphosphate | 1 |
| 67 | -acrylate | 1 |
| 68 | -piperidine-2-carboxylate | 1 |
| 69 | nh-responsive | 2 |
| 70 | aucl/nabarf | 1 |
| 71 | residing | 469 |
| 72 | majoring | 1 |
| 73 | specialising | 17 |
| 74 | hiv1-testing | 1 |
| 75 | recertifying | 1 |
| 76 | specializing | 67 |
| 77 | twice/month | 1 |
| 78 | min/tooth | 2 |
| 79 | microg/i | 1 |
| 80 | buli | 1 |
| 81 | .bsi | 1 |
| 82 | partook | 2 |
| 83 | h·mg/l | 3 |
| 84 | atom/l | 3 |
| 85 | -orbital | 1 |
| 86 | /val | 1 |
| 87 | standl | 2 |
| 88 | /docetaxel | 1 |
| 89 | c-verapamil | 2 |
| 90 | c-flumazenil | 1 |
| 91 | /trandolapril | 1 |
| 92 | bacteria/well | 1 |
| 93 | -3-hexen-1-ol | 1 |
| 94 | -petromyroxol | 1 |
| 95 | aa-isoform | 1 |
| 96 | acrossjapan | 1 |
| 97 | +hcn | 1 |
| 98 | reaven | 1 |
| 99 | -5-and-6-carboxy-fluorescein | 1 |
| 100 | shunrin | 1 |
| 101 | function/expression | 1 |
| 102 | -extubation | 1 |
| 103 | cyclocoagulation | 1 |
| 104 | c-accumulation | 1 |
| 105 | -concentration | 1 |
| 106 | -secretion | 1 |
| 107 | zubirán | 1 |
| 108 | /carbo | 1 |
| 109 | zr-dfo | 1 |
| 110 | +tio | 1 |
| 111 | eoc+p | 1 |
| 112 | phenyl-p | 3 |
| 113 | minitabs/syrup | 1 |
| 114 | ce-fcr | 1 |
| 115 | h-tg-fcr | 1 |
| 116 | neuver | 1 |
| 117 | /s-las | 1 |
| 118 | .colloids | 2 |
| 119 | ±oglds | 2 |
| 120 | -methanesulfonohydrazides | 1 |
| 121 | /species | 1 |
| 122 | -1-vinylpyrroles | 1 |
| 123 | 2-aryl-benzimidazoles | 1 |
| 124 | -1h-pyrazoles | 1 |
| 125 | -dienylsilanes | 1 |
| 126 | -1,3-dioxolanes | 1 |
| 127 | pyridine-2-amines | 2 |
| 128 | -o-phenylenediamines | 1 |
| 129 | pyrazol-3-ones | 1 |
| 130 | -en-8-ones | 1 |
| 131 | -β-aminomalonates | 1 |
| 132 | specializes | 6 |
| 133 | -thrombolysis | 4 |
| 134 | 2-thrombolysis | 2 |
| 135 | wisdoms | 2 |
| 136 | fulminans | 1 |
| 137 | -subfractions | 1 |
| 138 | dithioesters | 1 |
| 139 | -boosters | 1 |
| 140 | -generators | 1 |
| 141 | alikeness | 1 |
| 142 | -specialists | 1 |
| 143 | 70-plus | 1 |
| 144 | non-yet | 1 |
| 145 | klalit | 1 |
| 146 | didnt | 2 |
| 147 | diderot | 1 |
| 148 | ×tt | 1 |
| 149 | 06_cpx | 1 |
| 150 | -assay | 2 |
| 151 | dcfda-assay | 1 |
| 152 | showedhighfrequency | 1 |
| 153 | postpartumly | 1 |
| 154 | post-phototherapy | 1 |
| 155 | microspectrofluorimetry | 1 |
| 156 | -relaxometry | 1 |
| 157 | .tolerability | 1 |
| 158 | -enantioselectivity | 1 |